Pharmacovigilance Asia
10 Top Tips for Effective Pharmacovigilance
October 02 by Pharmaceuticals & Biotechnology Editor
There are several challenges around pharmacovigilance in Asia and perspectives are different for industry, regulatory authorities, academia and healthcare professionals. Ahead of the 5th Annual Phar...
6 Game-Changing Tips to Deal with Risk Management & Drug Safety Audit
April 04 by Pharmaceuticals & Biotechnology Editor
A Pharmacovigilance audit is important as it ensures the company’s drug safety and risk management procedures comply with applicable laws, regulations and guidance. While it could be a dauntin...
Asia Focus: Top 5 Challenges around Pharmacovigilance
June 14 by Deepa AroraThere are several challenges around pharmacovigilance in Asia and perspectives are different for Industry, regulatory authorities, academia and healthcare professionals. Dr Deepa Arora MD, Global He...
Lundbeck: Be Audit & Inspection Ready
May 31 by Niamh MadiganThe primary focus of Pharmacovigilance is patient safety. Raghavendra Pai, regional Pharmacovigilance Manager, Lundbeck Asia Pacific, explains the practical steps to train local pharmacov...
Implementing an Effective Pharamcovigilance Programme in India
May 30 by Niamh MadiganWith a population of 1.9 billion and a multi-medicine model, the reporting of adverse reactions in medicine in India is crucial. The pharmacovigilance programme was launched in India in 2010 to...
5 Challenges that Continue to Plague the $2 Billion Pharmacovigilance Sector
May 08 by Pharma IQThe Asia Pacific region is fast becoming the growth center of the worldwide pharmaceuticals market. By 2015, these markets are projected to account for almost a third of the total pharmaceutical sales...
Drug Safety Management in Japan: An Update on Current and Future Regulations
August 11 by Pharma IQJapan's pharmaceutical market is the second largest in the world but has long suffered from the so-called drug lag. Lengthy approval processes for drugs have seen medicines readily available...
Can New Media Improve the Output of Pharmacovigilance Data?
May 13 by Shaloo PandhiShaloo Pandhi, Group Head of Pharmacovigilance Operation at Novartis Healthcare, shares his insights on pharmacovigilance in India. Pharma IQ: There is an immense need to address...
Would ASEAN Accept Data and Reviews that Cross Borders?
August 11 by Bryan CamoensRobert Lim, Head of Haematology and Oncology, for the National University Cancer Institute, speaks exclusively to Bryan Camoens from Pharma IQ, on the fundamental difference between pharmacodili...
Pharmacovigilance in Asia: Will China One Day Take the Lead?
July 29 by Bryan CamoensJean Christophe Delumeau, Head of Pharmacovigilance Asia-Pacific for Bayer Healthcare Global R&D Centre, speaks exclusively to Bryan Camoens from Pharma IQ, on the evolution of Pharmacovigilance...
Case Study: Challenges in Japan on Post-Marketing Surveillance – Observational Study and EPPV Programme
April 18 by Bryan CamoensIn a session that will be discussed in detail at the 3rd Annual Pharmacovigilance Asia 2012, Dr. Shinichi Nishiuma, Senior Medical Advisor & Lead physician of Global Patient Safety in Japan for...
Offshore Outsourcing in Pharmacovigilance Set to Expand Rapidly
April 18 by Humaira QureshiIn this interview Humaira Qureshi, Vice President Pharmacovigilance, Outsourcing, Kinapse, speaks to Pharma IQ about improving drug safety and a move towards pharmacovigilance offshore outsourcing i...
